Metastatic Colorectal Cancers Completed Phase 2 Trials for Gemcitabine (DB00441)

Also known as: Colorectal cancer metastatic / Metastatic Colorectal Cancer

IndicationStatusPhase
DBCOND0063579 (Metastatic Colorectal Cancers)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01909830Gemcitabine in Combination With Pemetrexed Long Term Infusion in the Treatment of Pretreated Metastatic Colorectal Cancer PatientsTreatment
NCT01472770A Phase II Study of Gemcitabine and Capecitabine for Treatment Resistant, Metastatic Colorectal CancerTreatment